This article is more than 5 years old. Information may no longer be current.

VIDEO: CXL becoming first-line therapy for keratoconus

Issue: October 2017

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

LAS VEGAS – Corneal collagen cross-linking is quickly becoming the first line of treatment for progressive keratoconus, Clark Chang, OD, director of specialty contact lens, Wills Eye Hospital, and director of clinical services, TLC Vision, said here at Vision Expo West.

While the current treatment does not offer refractive correction, CXL with topography-guided PRK and photorefractive intrastromal CXL (under study) may address low refractive errors.